Seun Ajumobi’s Post

Investment Brief UnivLabs Technologies Pvt Ltd 👉 Introduction: UnivLabs is a pioneering medical devices company entering an exciting growth phase, marked by cutting-edge innovation, a robust intellectual property portfolio, and real-world manufacturing capabilities. With a strong foundation in research and a focus on practical, scalable solutions, UnivLabs is poised to redefine the future of healthcare technology. 👉 Key Highlights • Exponential Growth: UnivLabs is on track to achieve a 7x revenue increase compared to the past two years, fueled by expanding markets and breakthrough products. • Innovation-Driven: Backed by proprietary technologies and patents, UnivLabs ensures sustainable competitive advantages in the medical devices sector. • Global Presence: Research and Development offices in India and Europe provide a strategic edge, combining cost-effective innovation with access to global expertise. • Manufacturing Excellence: UnivLabs boasts in-house manufacturing, ensuring quality control and scalability to meet growing market demands. 👉 Market Opportunity: The global medical devices market is projected to grow at a CAGR of 5-6%, with increasing demand for high-quality, affordable healthcare solutions. UnivLabs addresses this demand by delivering innovative products across diagnostics, surgical equipment, and other essential medical technologies. 👉 Investment Rationale: 1. Proven Track Record: UnivLabs has demonstrated consistent growth, backed by successful product launches and market penetration. 2. Scalable Model: The company is strategically positioned to expand its footprint in emerging and developed markets, leveraging its R&D and manufacturing capabilities. 3. High Growth Potential: With a robust pipeline of products and a focus on underserved medical needs, UnivLabs offers significant upside for investors. 4. Sustainability: UnivLabs integrates innovation with affordability, ensuring long-term relevance in a competitive industry. 👉 Call to Action: UnivLabs is inviting strategic investors to partner in this growth journey, fueling the next phase of innovation, market expansion, and value creation. Your investment will support not only our vision to revolutionize healthcare but also deliver exceptional returns in a rapidly growing sector. For further discussions, please reach out to vivek@univlabs.in #InvestInInnovation #Startup #HealthcareRevolution #MedTechGrowth #ScalingHealthcare #VCOpportunities #FutureOfMedTech #InnovationDriven #MedicalDevicesStartup #GrowthPhaseInvesting #GlobalHealthTech #Startupfunding #PrivateEquity

Latest DON Therapeutics News The medtech industry, particularly the medical device sector, is experiencing a period of rapid transformation and growth. As one of the most innovative fields, it is at the forefront of technological advancements that have the potential to completely revolutionize global healthcare. These innovations are not only enhancing the quality and efficiency of medical treatments but also fundamentally changing the way individuals interact with and manage their own health. From wearable health monitors that provide real-time data to advanced diagnostic tools that enable early detection of diseases, medical devices are making healthcare more personalized and accessible. This transformation is fostering a more proactive approach to health management, empowering individuals to take control of their well-being in unprecedented ways. For emerging companies and investors, the medtech industry presents a unique opportunity. The demand for innovative medical solutions is growing, driven by an aging global population, increasing prevalence of chronic diseases, and a heightened focus on preventative care. This burgeoning market offers a fertile ground for investment and innovation, with the potential for significant financial returns and the ability to make a profound impact on global health. More about DON Therapeutics: https://lnkd.in/eKs-9g9e We are always looking for new healthcare opportunities. Submit your opportunity: https://lnkd.in/dJfhwVvv #funding #biotechnology #medtech #startups #investors

MedTech Innovator is the largest and highest-performing accelerator of medical technology in the world and the medtech industry’s premiere showcase and competition for innovative medical devices, digital health, and diagnostic companies. 95% of their companies are still in business or have been acquired, raising 30% of the global private funding invested in Medtech last year. The 1st stage is an online application. Afterwards, they run the Medtech Innovator Road Tour where 200 out of 1,400 applicants are invited to participate in one of a series of pitch events. Upfront Diagnostics has been invited to the International Pitch Event held on April 15 in Dublin. (https://lnkd.in/d-tY3aEf) After the event, 50+ companies will be selected to participate in the MedTech Innovator Accelerator. These companies will have access to corporate executives, investors, providers, payers, FDA, NIH, DoD, and other stakeholders. They will join an exclusive peer alumni network of 500+ of the highest-performing medtech startups around the world. In addition to receiving the above benefits, companies will compete for up to $500,000 in non-dilutive cash prizes. Pitch event judges include investors, providers, and senior executives from world-class medtech companies such as Johnson & Johnson, Becton Dickenson, Edwards Lifesciences, Dexcom, Olympus Corporation, Nipro Medical Corporation, and others. #TimeisLife APEX Ventures Cambridge Enterprise

🚀 Where is investment coming from for advanced medical technology? As someone deeply entrenched in the Medical Device sector, it's exciting to see the landscape evolving through significant investments. Lately, there has been a surge in funding from venture capital firms, governmental grants, and corporate partnerships. These funds are driving innovation, ensuring that the next generation of medical technology is not only cutting-edge but also accessible. 🌍 Venture capital is a major player, with firms increasingly focusing on MedTech startups that promise groundbreaking advancements. For instance, in the UK, MedCity reported a £998 million investment in life sciences over the past year. Government-backed initiatives, especially those emphasising automation and AI in medical devices, are creating a robust support system for innovators. Securing these grants and partnerships is becoming pivotal for companies aiming to stay competitive and progressive. 💼 It's not just about the money, though. The collaborations between tech giants and medical companies are fostering ecosystems where knowledge and resources are shared. This integration is crucial for bringing sophisticated devices to market faster. As a company that recruits top talent for Medical Device Manufacturing and Engineering, we see this as a golden age for those eager to make a significant impact in healthcare. 🌟 #MedTech #Innovation #HealthcareRevolution

In the latest episode of Medtech Talk, host Geoff Pardo speaks with Shifamed founder and CEO Amr Salahieh about how to successfully pursue the path of entrepreneurship. As the founder of several companies, including Sadra Medical, Maya Medical, and Apama Medical, Salahieh shares his methods behind finding the right markets and taking care of your investors. He also talks about his thoughts on the biggest challenge. Listen to the conversation here: https://lnkd.in/eHkfRraJ

MedTech Venture Investment is Bouncing Back The last few quarters have been tough for the life science industry, and I wanted to share a recent PitchBook report which shows there may be the light at the end of the tunnel at least for medical devices... and let's hope it spreads to the other segments as well. 📈 Q1 2024 saw USD 3.3 Bio in VC funding up from USD 2.8 Bio in Q4 2023. 🎯 At the current pace, MedTech VC funding activity for 2024 could result in the highest average annual deal value since early 2022. 🔬 Surgical devices & tools shows the largest 12-month activity, followed by Diagnostics. Get the pdf here: https://acesse.dev/A1fLz #medtech #healthcare #innovation #healthtech #medical #medicaldevice #digitalhealth #health #medicine #medicaltechnology #technology #medicaldevices #biotech #covid #startup #meddevice Photo by Markus Spiske on Unsplash

In the medical device industry, being in the operating room should be non-negotiable. When our salespeople AND engineers collaborate directly with surgical teams, we don’t just support procedures; we drive innovation. This hands-on approach allows us to gather real-time feedback, solve challenges instantly, and refine our products on the fly. It’s not just about selling devices; it’s about being a true partner in healthcare. This commitment sets VitaTek apart and leads to better patient outcomes. Let’s lead the way! —— #prototyping #rapidprototyping #contractmanufacturing #manufacturing #medical #medicaldevices #sterilization #medicaldevicemanufacturing #researchanddevelopment #researchdevelopment #equity #privateequity #capital #hydrophilic #coatings #diemolds #meddevice #doctors #technology #future #creativity #entrepreneurship #startups #leanstartups

“Accept the time it takes. You can move fast on technology development and fail fast. But probably slow down over the clinical and regulatory process, and then be prepared to accelerate really strongly on the back end of that.” Steffen Hovard, CEO of Neuspera Medical Inc., has spent over 30 years in the medical device field. At Coloplast, a Danish medtech company, he led major initiatives, including an acquisition that eventually brought him to the U.S. from Denmark. Now at Neuspera, Steffen is steering an innovative approach to neuromodulation technology. Neuspera’s device is designed to treat conditions like overactive bladder, using a less invasive, “microimplant” system that doesn’t require a traditional battery or bulky hardware. Here's a quick look at Steffen’s interview with Scott Nelson: 🌐 In medtech, development timelines can stretch over a decade. Before pouring resources into an idea, it’s crucial to confirm its relevance and market potential and then get the right people on board. Building your network early helps with finding the right talent as well as the right investors. 🕰️ Align your pace with the development stage you’re at. Move fast in early development but slow down and be thorough in the clinical stages. Then, be ready to pick up speed and go full throttle when commercialization approaches. 🔋Perfect your pitch and refine your story to make a strong impression. View each investor interaction as a long-term relationship rather than a one-time opportunity; stay in touch, and show consistent progress. Above all, bring energy and resilience to each pitch. Click the link in the comments for the full interview. This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. Don’t miss out on their next fundraise (more details in the comments). P.S. - We recently launched Medsider Mentors Volume VI, which is packed with insights and learnings from founders and CEOs of some of the most dynamic medical device and health technology startups in the world. Click the link in the comment section for this latest edition now available exclusively to our premium members.

We have selected 14 innovative medtech teams to participate in the Fall 2024 Aspire Medtech investor engagement program! We are impressed and inspired by these teams and their inventions, and thrilled to support them as they prepare for the next step in their entrepreneurial journeys. These medtech companies are developing inventions that include an attachment that converts a traditional wheelchair into a motorized one in just 30 seconds🦽; a low-cost atomizer device that delivers intranasal drugs faster during emergency situations 🚨; and low-cost wound dressings using smart biomaterials, empowering patients to heal and monitor their own wound infections 🩹; among others. For many promising technologies, funding becomes the barrier to scale. These companies will work closely with dedicated investor-mentors to dig deep into how to productively engage with investors. Learn more about their high-impact solutions and follow their progress: https://bit.ly/3N6u9eS

Did you know? The Life Sciences Investment Summit is back for a second time this year! 🎉 We're excited to partner once again with Startup TNT to bring together some of the brightest entrepreneurs in the life sciences and hear about their groundbreaking innovations! 🚀 Join us on October 10th to watch the leading companies pitch LIVE via Zoom! This is your opportunity to witness groundbreaking innovations and engage with the next wave of industry leaders! Stay tuned for an announcement about the top pitching companies coming soon. Register now 👉 https://bit.ly/LSVirtual24 #LifeSciences #InvestmentSummit #Innovation #Entrepreneurship #PitchEvent